e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 49

Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications

Sharmin Akter; Rajesh Madhuvilakku; Anik Kumar Kar; Irin Sultana Nila; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei; Yonggeun Hong · 2026 · Signal Transduction and Targeted Therapy

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Reactive oxygen species (ROS) act as critical secondary messengers in various intracellular signaling pathways that regulate cellular proliferation, differentiation, and survival under normal physiological conditions. However, dysregulation of redox signaling-driven by genetic mutations, epigenetic alterations, and posttranscriptional or posttranslational modifications-plays a central role in malignant transformation and cancer progression. Cancer cells typically exhibit elevated basal ROS levels due to increased metabolic activity, mitochondrial dysfunction, and oncogene activation. This mode

Abstract by Sharmin Akter; Rajesh Madhuvilakku; Anik Kumar Kar; Irin Sultana Nila; Pengda Liu; Hiroyuki Inuzuka; Wenyi Wei; Yonggeun Hong, Signal Transduction and Targeted Therapy (2026) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1038/s41392-026-02583-x